Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by Obhan & AssociatesAparna Kareer and Sneha Agarwal of Obhan & Associates discuss the provisions of Indian patent law under which experimental data is required, the nature of the data and submission stages -
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property considers the impact of the structure-activity relationship on the inventiveness assessment of pharmaceutical compounds
-
Sponsored by FB RicePaul Whenman and David Herman of FB Rice explain the concept of a whole of contents document
-
Sponsored by Liu, Shen & AssociatesJian Zhang and Jinhua Deng of Liu Shen & Associates consider why a valuable 5G SEP requires a proper patent drafting and prosecution strategy
-
Sponsored by Remfry & SagarCyril Abrol of Remfry & Sagar discusses the regulatory benchmarks for cryptocurrencies and non-fungibles tokens and why India could become a hub of crypto innovation
-
Sponsored by GEN Law FirmHe Jing and Gu Xiaoman of GEN Law Firm discuss the key features of China’s patent linkage system
